Journal of Medicinal Chemistry (44) Coleman, R. S.; Kesicki, E. A. Synthesis and postsynthetic modification of oligodeoxynucleotides containing 4-thio-2′-deoxyur- idine (D(S4)U. J. Am. Chem. Soc. 1994, 116, 11636−11642. (45) Coleman, R. S.; Kesicki, E. A.; Arthur, J. C.; Cotham, W. E. Analysis of post-synthetically modified oligodeoxynucleotides by electrospray-ionization mass-spectrometry. Bioorg. Med. Chem. Lett. 1994, 4, 1869−1872. (46) Coleman, R. S.; Arthur, J. C.; McCary, J. L. 6-Thio-2′-deoxy- inosine: synthesis, incorporation, and evaluation as a post-synthetically modifiable base in oligonucleotides. Tetrahedron 1997, 53, 11191− 11202. (47) Kadokura, M.; Wada, T.; Seio, K.; Sekine, M. Synthesis of 4- thiouridine, 6-thioinosine, and 6-thioguanosine 3′,5′-O-bisphosphates as donor molecules for RNA ligation and their application to the syn- thesis of photoactivatable TMG-capped U1 snRNA fragments. J. Org. Chem. 2000, 65, 5104−5113. (48) Zheng, Q. G.; Wang, Y.; Lattmann, E. Synthesis of S-6-(2,4- dinitrophenyl)-6-thioguanosine phosphoramidite and its incorporation into oligoribonucleotides. Bioorg. Med. Chem. Lett. 2003, 13, 3141− 3144. (49) Worner, K.; Strube, T.; Engels, J. W. Synthesis and stability of GNRA-loop analogs. Helv. Chim. Acta 1999, 82, 2094−2104. (50) Moffatt, J. G.; Khorana, H. G. Nucleoside polyphosphates. X. The synthesis and some reactions of some nucleoside-5′ phosphor- omorpholidates and related compounds. Improved methods for the preparation of nucleoside-5′ polyphosphates. J. Am. Chem. Soc. 1961, 83, 649−658. (51) Lee, J.; Churchil, H.; Choi, W. B.; Lynch, J. E.; Roberts, F. E.; Volante, R. P.; Reider, P. J. A chemical synthesis of nicotinamide adenine dinucleotide (NAD(+)). Chem. Commun. 1999, 729−730. (52) Moreau, C.; Wagner, G. K.; Weber, K.; Guse, A. H.; Potter, B. V. L. Structural determinants for N1/N7 cyclization of nicotinamide hypoxanthine dinucleotide derivatives by ADP-ribosyl cyclase from Aplysia californica: Ca2+-mobilizing activity of 8-substituted cyclic inosine 5′-diphosphoribose analogs in T-lymphocytes. J. Med. Chem. 2006, 49, 5162−5176. (53) Schnackerz, K. D.; Vu, C. Q.; Gani, D.; Alvarez-Gonzalez, R.; Jacobson, M. K. Characterization of cyclic ADP-ribose and 2′-phospho- cyclic-ADP-ribose by P-31 NMR spectroscopy. Bioorg. Med. Chem. Lett. 1997, 7, 581−586. (54) Kudoh, T.; Fukuoka, M.; Ichikawa, S.; Murayama, T.; Ogawa, Y.; Hashii, M.; Higashida, H.; Kunerth, S.; Weber, K.; Guse, A. H.; Potter, B. V. L; Matsuda, A.; Shuto, S. Synthesis of stable and cell-type selective analogues of cyclic ADP-ribose, a Ca2+-mobilizing second messenger. Structure−activity relationship of the N1-ribose moiety. J. Am. Chem. Soc. 2005, 127, 8846−8855. (55) Moreau, C.; Ashamu, G. A.; Bailey, V. C.; Galione, A.; Guse, A. H.; Potter, B. V. L. Synthesis of cyclic adenosine 5′-diphosphate ribose analogues: a C2′ endo/syn “southern” ribose conformation underlies activity at the sea urchin cADPR receptor. Org. Biomol. Chem. 2011, 9, 278−290. (56) Altona, C.; Sundaralingam, M. Conformational analysis of sugar ring in nucleosides and nucleotides. Improved method for interpre- tation of proton magnetic resonance coupling constants. J. Am. Chem. Soc. 1973, 95, 2333−2344. (57) Stolarski, R.; Dudycz, L.; Shugar, D. NMR-studies on the syn− anti dynamic equilibrium in purine nucleosides and nucleotides. Eur. J. Biochem. 1980, 108, 111−121. (58) Rosemeyer, H.; Toth, G.; Golankiewicz, B.; Kazimierczuk, Z.; Bourgeois, W.; Kretschmer, U.; Muth, H. P.; Seela, F. Syn−anti conformational analysis of regular and modified nucleosides by 1D H- 1 NOE difference spectroscopy. A simple graphical-method based on conformationally rigid molecules. J. Org. Chem. 1990, 55, 5784−5790. (59) Bailey, V. C. Chemo-Enzymatic Synthesis of Mimics of Cyclic Adenosine 5′-Diphosphate Ribose. Ph.D. Thesis, University of Bath, U.K., 1997. (60) Zhang, F. J.; Sih, C. J. Novel enzymatic cyclizations of pyridine nucleotide analogs: cyclic GDP-ribose and cyclic HDP-ribose. Tetrahedron Lett. 1995, 36, 9289−9292. Article (61) Zhang, B. Synthesis and Biological Evaluation of cADPR and NAADP Analogues. Ph.D. Thesis, University of Bath, U.K., 2006. (62) Zhang, B.; Müller-Steffner, H.; Schuber, F.; Potter, B. V. L. Nicotinamide 2-fluoroadenine dinucleotide unmasks the NAD(+) glycohydrolase activity of Aplysia californica adenosine 5′-diphosphate ribosyl cyclase. Biochemistry 2007, 46, 4100−4109. (63) Graeff, R.; Liu, Q.; Kriksunov, I. A.; Kotaka, M.; Oppenheimer, N.; Hao, Q.; Lee, H. C. Mechanism of cyclizing NAD to cyclic ADP- ribose by ADP-ribosyl cyclase and CD38. J. Biol. Chem. 2009, 284, 27629−27636. (64) Liu, Q.; Graeff, R.; Kriksunov, I. A.; Jiang, H.; Zhang, B.; Oppenheimer, N.; Lin, H. N.; Potter, B. V. L; Lee, H. C.; Hao, Q. Structural basis for enzymatic evolution from a dedicated ADP-ribosyl cyclase to a multifunctional NAD hydrolase. J. Biol. Chem. 2009, 284, 27637−27645. (65) Munshi, C.; Thiel, D. J.; Mathews, I. I.; Aarhus, R.; Walseth, T. F.; Lee, H. C. Characterization of the active site of ADP-ribosyl cyclase. J. Biol. Chem. 1999, 274, 30770−30777. (66) Chenon, M. T.; Pugmire, R. J.; Grant, D. M.; Panzica, R. P.; Townsend, L. B. Carbon-13 magnetic-resonance. 26. Quantitative determination of tautomeric populations of certain purines. J. Am. Chem. Soc. 1975, 97, 4636−4642. (67) Hellmich, M. R.; Strumwasser, F. Purification and character- ization of a molluscan egg-specific NADase, a 2nd-messenger enzyme. Cell Regul. 1991, 2, 193−202. (68) Briggs, A. P. A modification of the Bell−Doisy phosphate method. J. Biol. Chem. 1922, 53, 13−16. (69) Guse, A. H.; Roth, E.; Emmrich, F. Intracellular Ca2+ pools in Jurkat T-lymphocytes. Biochem. J. 1993, 291 (Part2), 447−451. (70) Guse, A. H.; Roth, E.; Emmrich, F. D-myo-Inositol 1,3,4,5- tetrakisphosphate releases Ca2+ from crude microsomes and enriched vesicular plasma-membranes, but not from intracellular stores of permeabilized T-lymphocytes and monocytes. Biochem. J. 1992, 288, 489−495. (71) Rosenberg, H. J.; Riley, A. M.; Laude, A. J.; Taylor, C. W.; Potter, B. V. L. Synthesis and Ca2+-mobilizing activity of purine- modified mimics of adenophostin A: a model for the adenophostin- Ins(1,4,5)P3 receptor interaction. J. Med. Chem. 2003, 46, 4860−4871. 1489 dx.doi.org/10.1021/jm201127y | J. Med. Chem. 2012, 55, 1478−1489